Skip to main content

Mirae Asset Global Investments Co., Ltd.

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1569395 SEOUL, M5

Position in LYEL

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$14,668
-$7,558 QoQ
Shares Held
1,044
-5.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 87 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,560,803 across 207 Biotechnology names. LYEL ranks #176 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LYEL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,668 1,044
2026-03-31 $22,226 1,108
2025-12-31 $31,734 1,031
2025-09-30 $12,066 743
2025-06-30 $5,038 570
2025-03-31 $5,259 9,776
2024-12-31 $5,955 9,305
2024-09-30 $12,777 9,259
2024-06-30 $11,035 7,611
2023-12-31 $437,480 225,506
2023-09-30 $28,758 19,564
2023-06-30 $53,327 16,770
2023-03-31 $59,792 25,336
2022-12-31 $317,719 91,562
2022-09-30 $670,233 91,437
2022-06-30 $315,743 48,427